434 related articles for article (PubMed ID: 16155028)
41. Floral leukemic cells transformed from marginal zone lymphoma.
Chang ST; Hsieh YC; Lu YH; Tzeng CC; Lin CN; Chuang SS
Pathol Res Pract; 2008; 204(1):23-6. PubMed ID: 17913385
[TBL] [Abstract][Full Text] [Related]
42. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
43. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
[TBL] [Abstract][Full Text] [Related]
44. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
Iwai H; Nakamichi N; Nakae K; Konishi M; Inaba M; Hoshino S; Baba S; Amakawa R
Laryngoscope; 2009 Aug; 119(8):1491-4. PubMed ID: 19504556
[TBL] [Abstract][Full Text] [Related]
45. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Grünberger B; Wöhrer S; Streubel B; Formanek M; Petkov V; Puespoek A; Haefner M; Hejna M; Jaeger U; Chott A; Raderer M
J Clin Oncol; 2006 Mar; 24(9):1370-5. PubMed ID: 16549831
[TBL] [Abstract][Full Text] [Related]
46. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
47. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
48. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
Ferrucci PF; Zucca E
Br J Haematol; 2007 Feb; 136(4):521-38. PubMed ID: 17156403
[TBL] [Abstract][Full Text] [Related]
49. MALT lymphomas: pathogenesis can drive treatment.
Bertoni F; Coiffier B; Salles G; Stathis A; Traverse-Glehen A; Thieblemont C; Zucca E
Oncology (Williston Park); 2011 Nov; 25(12):1134-42, 1147. PubMed ID: 22229204
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Swisher SC; Barbati AJ
Gastroenterol Nurs; 2007; 30(5):348-54; quiz 355-6. PubMed ID: 18049205
[TBL] [Abstract][Full Text] [Related]
51. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma.
Lamarque D; Levy M; Chaumette MT; Roudot-Thoraval F; Cavicchi M; Auroux J; Courillon-Mallet A; Haioun C; Delchier JC
Am J Gastroenterol; 2006 Aug; 101(8):1886-93. PubMed ID: 16780555
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
[TBL] [Abstract][Full Text] [Related]
53. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.
Boveri E; Arcaini L; Merli M; Passamonti F; Rizzi S; Vanelli L; Rumi E; Rattotti S; Lucioni M; Picone C; Castello A; Pascutto C; Magrini U; Lazzarino M; Paulli M
Ann Oncol; 2009 Jan; 20(1):129-36. PubMed ID: 18718888
[TBL] [Abstract][Full Text] [Related]
54. [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
Gershanovich ML; Petrov LN; Dobritsa VP; Kalinovskiĭ VP; Nikitina MV
Vopr Onkol; 2006; 52(6):696-8. PubMed ID: 17338252
[No Abstract] [Full Text] [Related]
55. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
[TBL] [Abstract][Full Text] [Related]
56. Marginal zone B-Cell lymphoma among primary B-Cell lymphoma of Waldeyer's ring: histopathologic and immunohistochemical study of 16 tonsillectomy specimens.
Kojima M; Nakamura N; Shimizu K; Tamaki Y; Itoh H; Nakamura S
Int J Surg Pathol; 2008 Apr; 16(2):164-70. PubMed ID: 18417673
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
58. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century.
Raderer M; Isaacson PG
Expert Rev Anticancer Ther; 2001 Jun; 1(1):53-64. PubMed ID: 12113133
[TBL] [Abstract][Full Text] [Related]
59. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
60. Dissemination patterns in non-gastric MALT lymphoma.
de Boer JP; Hiddink RF; Raderer M; Antonini N; Aleman BM; Boot H; de Jong D
Haematologica; 2008 Feb; 93(2):201-6. PubMed ID: 18223283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]